NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report
Abstract Background NeuroAid II (MLC901) is a promising therapy for stroke patients who present outside of therapeutic window for reperfusion therapy. Studies have proven its efficacy in ischemic stroke; however, data of drug safety and combination with other medications especially anticoagulants ar...
Saved in:
Main Authors: | Anna Misya’il Abdul Rashid, Mohamad Syafeeq Faeez Md Noh, Abdul Hanif Khan Yusof Khan, Wei Chao Loh, Janudin Baharin, Azliza Ibrahim, Liyana Najwa Inche Mat, Wan Aliaa Wan Sulaiman, Fan Kee Hoo, Fazah Akhtar Hanapiah, Hamidon Basri |
---|---|
Format: | article |
Language: | EN |
Published: |
SpringerOpen
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8e2912eb01e540368284ee5b4ff77d01 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A protocol for a systematic review of controlled trials.
by: Nabil Izzaatie Mohamad Safiai, et al.
Published: (2021) -
Acta Nº901
by: Banco Central de Chile
Published: (2019) -
Sustained-release nanoART formulation for the treatment of neuroAIDS
by: Jayant RD, et al.
Published: (2015) -
Hot Deformation Behavior and Processing Map of GH901 Superalloy
by: Rui Ma, et al.
Published: (2021) -
MLC601 in vascular dementia: an efficacy and safety pilot study
by: Pakdaman H, et al.
Published: (2017)